For Wegovy (weight management), the schedule starts at 0.25 mg weekly and increases monthly through 0.5 mg, 1 mg, 1.7 mg, and finally to the maintenance dose of 2.4 mg weekly
However, in conditions like type 2 diabetes, endogenous GLP-1 secretion may be impaired, reducing its glucose-lowering and weight management effects
Untreated or undertreated inflammatory arthritis can lead to irreversible joint damage, disability, and chronic pain
Both colonic GCG expression and GLP-1+ cell density increase in patients with type 2 diabetes compared to healthy individuals (Jorsal et al., 2018)
This means they have not gone through the rigorous testing all skincare products go through before being available to the public